DiA Imaging Analysis, a Be’er Sheva, Israel-based artificial intelligence medical imaging analysis startup, closed a $5m funding round.
The round was led by Connecticut Innovations with participation from Defta Healthcare, existing investors and a government grant from the Israel Innovation Authority.
The company plans to use the new capital to continue penetrating the market with its FDA/CE-approved automated tools while at the same time expanding its portfolio and building support teams for its activities in the United States, Europe and Asia.
Founded by Hila Goldman Aslan (CEO), Michal Yaacobi (VP R&D) and Arnon Toussia-Cohen (VP BD), DiA Imaging Analysis is a medical imaging analysis software company providing fully automated, implementable tools that enable quick, objective and accurate ultrasound analysis, with the first product line in echocardiography. The company’s FDA- and CE-cleared cognitive image processing tools are based on advanced pattern recognition and machine learning algorithms that automatically imitate the way the human eye identifies borders and motion, producing accurate and reliable data for the use of physicians.
DiA is collaborating with market leaders including GE Healthcare, Neusoft Medical System, Google Cloud and others to implement its FDA/CE-approved automated tools within ultrasound devices, healthcare IT systems and cloud platforms. The company has reference cites in leading US medical centers, including Yale, Mount Sinai, RUSH, USF and UCSD. DiA’s Scientific Advisory Board is supported by world-leading physicians specializing in cardiology and primary care ultrasound.